Market Inference Overview — LU Stock

Large-cap Financial Services company Lufax has moved -10.4% so far today on a volume of 12,342,672, compared to its average of 16,136,780. In contrast, the S&P 500 index moved 0.5%

Lufax trades -40.12% away from its average analyst target price of $3.44 per share. The 20 analysts following the stock have set target prices ranging from $1.4 to $8.8, and on average have given Lufax a rating of buy.

Anyone interested in buying LU should be aware of the facts below:

  • Lufax's Graham number (a purchase price with a built-in margin of safety) is $26.61, which is -92.3% away from its current price

  • Lufax has moved -62.5% over the last year, and the S&P 500 logged a change of -15.7%

  • Based on its trailing earning per share of 0.77, Lufax has a trailing 12 month Price to Earnings (P/E) ratio of 2.7 while the S&P 500 average is 15.97

  • LU has a forward P/E ratio of 5.0 based on its forward 12 month price to earnings (Eps) is $0.41 per share

  • The company has a price to earnings growth (PEG) ratio of 45.1 -- a number near or below 1 signifying that Lufax is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 0.1 compared to its sector average of 1.95

  • Lufax Holding Ltd operates a technology-empowered personal financial services platform in China.

  • Based in Shanghai, the company has 92,380 full time employees and a market cap of $4,708,768,256. Lufax currently returns an annual dividend yield of 146.5%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.